Elrov Properties & Lodgings 2025: Profit surged, but the proof still sits in hotels and cash

Getting To Know The Company

At first glance, Elrov looks like a real estate company with a luxury hotel portfolio. That is only half the picture. In practice, this is a mixed platform with four different layers: investment property in Israel and Switzerland, luxury hotels in Israel and Europe, a large financial holding in Clal Insurance, and a handful of assets and projects whose value currently sits more in the balance sheet than in cash flow. Because of that structure, Elrov can print a very strong bottom line even in a year when the core operating picture is still not clean.

That is exactly what happened in 2025. Net profit jumped to ILS 1.415 billion from ILS 386 million in 2024, while total equity rose to ILS 9.121 billion. A superficial read sees a breakout year. A closer read sees something else: ILS 1.469 billion of profit from marketable securities, ILS 224 million of investment property fair value gains, a one-off ILS 201 million income item from Karta, and against that only ILS 87 million of hotel operating profit and ILS 142 million of operating cash flow, which was also helped by several years of rent collected in advance in Switzerland.

What is working now is the balance sheet. Working capital moved from a negative ILS 503 million to a positive ILS 805 million. Epic Suisse raised equity, Elrov’s holding fell to 52.4%, but group equity still increased by ILS 262 million. Café Royal is unencumbered, Lutetia still carries debt headroom, and in January 2026 Mamilla signed a space sale at fair value. In other words, not all the value here is purely accounting.

The active bottleneck is that Elrov still does not show a sufficiently consistent translation of balance-sheet value into operating earnings and accessible cash. Asia House is a good example: a property carried at ILS 648 million, mostly vacant, excluded from the NOI tables, with a large plan whose expected construction start is only in 2027. The foreign hotels are also in a transition year under Mandarin Oriental. That is why 2026 looks more like a bridge year with a proof test than a year when the operating case is already fully clean.

Economic Map

That chart matters because it fixes the frame. There is a real real-estate core here, but it leans heavily on Switzerland. If the market reads Elrov only through the hotel business, it misses the story. If it reads Elrov only through Clal Insurance and the balance sheet, it misses it as well.

Events And Triggers

The first trigger: Epic Suisse issued 875 thousand shares in December 2025 at CHF 80 per share. Elrov participated, but its holding fell from 56.4% to 52.4%. This is a classic two-sided move: some dilution on the economic interest, but also a clear ILS 262 million increase in group equity and better balance-sheet flexibility.

The second trigger: Karta moved from being a legacy legal story to being current-year earnings. In 2025 the group booked about ILS 201 million before tax under other income after the creditor arrangement became final in July 2025. That is more tangible than a revaluation gain, but it is still fully one-off. Anyone who normalizes it into 2026 is overstating the base.

The third trigger: In January 2026, the group signed an agreement to sell space in Mamilla for ILS 100 million, with the price reflecting fair value for the sold portion. That is an important signal because it shows that at least part of the balance-sheet value is capable of meeting the market at prices close to book.

The fourth trigger: After the balance-sheet date, the group refinanced loans that were weighing on current liabilities. The Conservatorium loan in Amsterdam, which stood at about ILS 381 million at year-end and was classified as current, was extended for three years and increased by EUR 23 million. A London property loan of about GBP 39 million was extended by five years. That reduces immediate pressure, but it does not change the fact that flexibility still depends heavily on asset-backed funding.

The fifth trigger: Right after year-end, the company also got a reminder of why this is not yet a clean operating story. According to the filing, the military campaign that began on February 28, 2026 materially hurt Jerusalem hotel activity in March 2026 and led to cancellations for April as well. So the 2025 recovery in Israel is already being tested again.

That bridge captures the deeper point. The balance sheet genuinely improved, but a large part of the improvement still came through accounting gains and equity events, not through wide and clean free cash generation.

Efficiency, Profitability And Competition

Investment Property, Stable But Not Accelerating

Rental income was nearly flat at ILS 478 million versus ILS 479 million in 2024. That is not a bad outcome in a year when London assets went through tenant adjustments, but it is not the number of a sharply accelerating platform either. Total NOI fell to ILS 444.6 million from ILS 450.6 million, and same-property NOI fell to the same level. In other words, the core property layer is not yet showing clean organic growth.

That said, the picture is not weak. Swiss income benefited from the completion of two additional assets and lower vacancy, and Epic Suisse itself ran at a net loan-to-value ratio of only 35.5%. In addition, 88.7% of Swiss rent is CPI-linked, the weighted average lease term there stands at 7.9 years, and more than 170 tenants spread the portfolio. That is a real quality layer.

The yellow flag sits beneath the diversification headline: the top five tenants at Epic Suisse account for 46.6% of rental income, and Coop alone accounts for 19.4%. That is not enough to break the platform, but it does mean the Swiss story is less diversified than it sounds on a quick read.

That is the core real-estate message. NOI did not collapse, but it did not break out either. Revaluation gains, by contrast, remained high. This is not an accounting problem. It is a reading problem. Anyone who looks only at the real-estate profit line gets a cleaner picture than the operating pace actually supports.

Hotels, Israel Improved, Europe Is Still Looking For Shape

The biggest 2025 gap sits between Jerusalem and Europe. In Israel, revenue rose to ILS 229.8 million from ILS 178.7 million, EBITDA rose to ILS 43.3 million from ILS 23.1 million, average occupancy rose to 38% from 30%, and RevPAR rose to ILS 668 from ILS 483. Room pricing also improved sharply, to about USD 546 at the David Citadel and USD 468 at Mamilla.

Abroad, the story is less clean. Revenue fell to ILS 515.5 million from ILS 529.7 million, while EBITDA fell to ILS 43.1 million from ILS 74.9 million. At first that looks odd, because average occupancy actually improved to 59% from 53%. The explanation is the mix of pricing, mix and a new management model: Café Royal’s average room rate fell to GBP 632 from GBP 685, Lutetia fell to EUR 1,233 from EUR 1,258, and Conservatorium fell to EUR 709 from EUR 732. More occupancy did not translate into more profit.

That chart sharpens why 2025 is a transition year. Israel is rebounding from a very weak 2024 base. Europe is not collapsing, but it is also not giving the clean profit lift one might have expected after the management switch.

Mandarin Oriental Has Not Yet Proved Itself

Conservatorium and Lutetia moved to Mandarin Oriental management and operation in April 2025. This is a move with both strategic logic and a clear cost. On the one hand, there is a stronger brand, better distribution, and in theory a better path to higher room revenue over time. On the other hand, there is a base fee that rises from 2% of gross revenue in year one to 3% from year three onward, a 10% incentive fee on adjusted gross operating profit, and another 2.5% tied to sales, marketing and promotion.

The 2025 numbers do not yet tell a proof story. Lutetia’s operating surplus fell to ILS 22 million from ILS 48 million. Conservatorium moved to a negative ILS 5 million operating surplus from a positive ILS 4 million. But the market comparison is more nuanced: Lutetia still delivered a 4% RevPAR increase while Paris luxury hotels were down 4%, and Conservatorium was down only 2.1% versus a 4% decline in Amsterdam luxury hotels. Anyone who breaks too quickly from the first year may miss that the rebranding could still be improving commercial resilience even before it shows up in profit.

The company itself signals the scorecard. Under the management agreements, meeting the 2026 operating targets is expected to deliver not less than EUR 20 million of operating surplus from Lutetia and Conservatorium. Put differently, 2025 is not the target year. It is the preparation year for the target year.

Cash Flow, Debt And Capital Structure

The All-In Cash Picture

The framing matters here. I am using an all-in cash view, not a normalized maintenance-cash view. In other words, the question is how much cash is left after actual uses of cash, not how much the business might have produced in a cleaner theoretical year.

From that angle, 2025 looks less impressive than the earnings line. Operating cash flow rose to ILS 142 million, but investment property spending was ILS 107 million, fixed-asset spending was ILS 43 million, and dividends to shareholders and non-controlling interests totaled ILS 72 million. Before refinancing and capital-market activity, operating cash did not cover all actual uses.

And that is before cash-quality issues. The company explains that part of the improvement in cash flow came from collecting several years of rent in advance under a long-term Swiss lease. That is a key point. Cash collected upfront improves the current year, but it does not recur every year. So it would be wrong to read the entire CFO improvement as structural.

That chart shows Elrov’s paradox. Cash, the securities portfolio and equity all rose sharply. But the debt load is still substantial, so genuine flexibility depends not only on the size of the assets but also on how quickly they can be monetized or financed.

Debt, Covenants And Headroom

The big credit point of 2025 is that the financial test now looks further from the wall. The company reports that it complies with all covenants at year-end. At the Mamilla complex, the calculated LTV on the updated facility stood at 48.6% against an 80% ceiling. In the Lutetia-backed secured bond series, the liability value stood at roughly EUR 206 million, only about 43% of Lutetia’s value, while an accelerated-repayment trigger appears only above 75% for two consecutive quarters. Those are comfortable cushions.

There is also better optionality on the funding side. Around the signing date, the group had about ILS 497 million of unused bank facilities. Café Royal and its adjacent retail areas are unencumbered and carried at GBP 305.2 million. In addition, under certain conditions the company could in theory expand the Lutetia-backed series by another roughly EUR 30 million.

But again, the easy conclusion would be the wrong one. The headroom here is built mainly on trophy assets and an open debt market, not on a business that already throws off large cash surpluses on its own. The accounts also show that the Conservatorium and London loans were classified as current at the end of 2025 until they were refinanced after the balance-sheet date. That is not a distress sign, but it is a reminder that Elrov’s stronger balance sheet still works best when markets are open and assets remain financeable.

There is another important point in Switzerland. Most bank debt there is based on SARON, 66.2% of Swiss bank loans are floating-rate, and only 53.5% of that floating debt is hedged into fixed terms. So even after some hedging, rate sensitivity remains. That is much easier to live with when net LTV is 35.5%, but it still means the improvement in flexibility does not eliminate dependence on a reasonable funding environment.

Outlook And Forward View

Five Things To Measure In 2026

First checkpoint: whether Lutetia and Conservatorium turn the Mandarin Oriental move into profit, not just branding. The company itself sets an ambitious bar of at least EUR 20 million of operating surplus in 2026 if the operating targets are met. That is now a measurable proof point.

Second checkpoint: whether the Jerusalem hotel recovery survives the March 2026 hit. 2025 showed a nice rebound, but it came off a very weak 2024 base. The next test is no longer whether there is recovery versus 2024, but whether that recovery can hold.

Third checkpoint: whether NOI returns to organic growth. 2025 was helped by the completion of two Swiss assets, lower vacancy and rent collected upfront. What is still missing is growth that comes from recurring operations rather than transition events.

Fourth checkpoint: whether Asia House moves from business-plan value to an execution track. At this point the company is talking about 78 thousand square meters, total cost of ILS 1.008 billion and expected construction starting in 2027. Under the company’s assumptions, apartment sales are expected to cover the full cost of the plan. Until the project moves another step, that remains future value rather than accessible cash.

Fifth checkpoint: whether securities gains continue to support value after year-end. The report already shows another roughly ILS 226 million of pre-tax gain through March 27, 2026. That can keep the short-term narrative constructive, but it does not resolve the quality-of-earnings question.

What Kind Of Year 2026 Looks Like

2026 looks like a bridge year with a proof test. Not a reset year, because the balance sheet is stronger and the company is no longer operating from pure financial pressure. But also not a clean breakout year, because too many moving parts still depend on the next event: tourism recovery, Mandarin execution, the value of the securities portfolio, Asia House planning, and the ability to keep refinancing on acceptable terms.

The positive scenario is easy to see. Epic Suisse can keep paying dividends, Lutetia and Conservatorium can turn their transition year into an earnings year, Clal Insurance can keep supporting equity, and Mamilla transactions can show that book value is monetizable. If all of those happen together, the read on Elrov changes from a balance-sheet value story into a platform that can surface more accessible value.

The weaker scenario is just as clear. If March 2026 becomes the start of a longer weak period in Jerusalem, if Mandarin does not move the foreign hotels into a better profitability phase, and if NOI remains stuck, the company will still have a stronger balance sheet but not a sufficiently convincing operating engine. In that case, the market may keep giving much more weight to asset values and marketable securities than to the business’s ability to generate cash.

What Could Change The Market Read In The Near Term

In the coming days, weeks and quarters, the market is likely to focus on four things. First, Jerusalem hotel performance after March 2026. Second, whether the company monetizes more property value at prices that validate book value. Third, whether Clal-driven securities gains continue to support mark-to-market profit after the signing date. Fourth, whether the working-capital improvement really signals lower risk or turns out to be more dependent on advance rent and refinancing than it first appears.

Risks

Profit On Paper, Not Yet Recurring Profit

The first risk is earnings quality. In 2025, securities gains alone were larger than total net profit. That makes clear how sensitive reported performance is to capital-market moves. Even if this is not a balance-sheet problem, it is a profit-base problem.

The second risk is that Asia House keeps accumulating value on paper without contributing cash. The property is mostly vacant, excluded from the NOI tables, and its economic upside still depends on planning, permits, execution costs and timing. This is not just a time issue. It is also a question of how much capital, management attention and market patience will be required before the asset turns from a beautiful balance-sheet number into an economic engine.

Hotels, External Sensitivity And Brand Execution

The Israeli hotel business is directly exposed to the security situation. The company explicitly says it still cannot estimate the full impact of the late-February and early-March 2026 events, but it already identifies a material effect on operations. That is a clear external risk.

In the foreign hotels, the risk is different: not security but commercialization. The Mandarin Oriental move should improve performance, but 2025 did not yet prove it. So there is a double execution risk here, both in occupancy and pricing and in the conversion of that activity into profit after management, incentive and marketing fees.

Concentration, Regulation And Funding

Epic Suisse has broad diversification, but not full diversification. The top five tenants account for 46.6% of rental income, and Coop alone is almost one fifth of that. In the securities portfolio, Clal Insurance is an even larger anchor. That holding supports the balance sheet, but after the control-permit application was withdrawn in June 2025 it looks more like a large financial investment and less like an open strategic control path.

Funding remains a risk too, just a better-controlled one for now. Compliance with covenants is clearly positive, but part of the flexibility still depends on an available debt market, on the ability to pledge or refinance assets, and on a rate environment that does not deteriorate again. This is more comfortable than in 2024. It is not a point where funding ceases to matter.

Conclusions

Elrov exits 2025 with a better balance sheet, more equity and more optionality around its flagship assets. That is the positive side. The less clean side is that the very large profit still leans heavily on Clal Insurance, revaluations and a one-off legal settlement, while the hotels, Asia House and cash flow have not yet delivered full proof. In the near term, the market will mainly measure what comes next in hotels, whether value can be monetized from assets, and whether 2025 was the start of a deeper improvement or simply a very strong year on paper.

Current thesis: Elrov now looks less like a balance-sheet pressure story and more like a value platform with better room to maneuver, but it still needs to prove that balance-sheet value can become operating profitability and accessible cash.

What changed versus the 2024 read is fairly clear. The balance sheet improved, working capital turned positive, Epic Suisse added equity, and financial pressure looks lower. At the same time, operating performance still does not provide a clean enough base to justify a simple breakout reading.

Counter-thesis: the market may still be too conservative because it is not giving enough credit to the improved balance-sheet quality, the funding room around Café Royal and Lutetia, the expected Epic Suisse dividend, and the fact that Mamilla already validated part of book value through a transaction.

What could change the market read in the short to medium term is also clear: continued recovery or renewed weakness in Jerusalem hotels, real profitability proof under Mandarin Oriental, and continued support from the securities portfolio. Why this matters: because at Elrov, the gap between value created and value that is actually accessible to shareholders remains the central question.

Over the next 2 to 4 quarters, the thesis strengthens if foreign hotels improve profitability, if NOI returns to growth without one-off support, and if Asia House moves one more step forward on planning or execution. It weakens if March 2026 becomes the start of a softer Jerusalem demand environment, or if the 2025 improvement proves to be mostly a function of financial markets and revaluations.